Market Cap 4.07B
Revenue (ttm) 0.00
Net Income (ttm) -359.64M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,402,400
Avg Vol 2,053,600
Day's Range N/A - N/A
Shares Out 116.65M
Stochastic %K 96%
Beta 0.69
Analysts Strong Sell
Price Target $88.61

Company Profile

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. The company develops VK5211, an orally available non-steroidal selective...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 704 4660
Address:
9920 Pacific Heights Boulevard, Suite 350, San Diego, United States
DG20
DG20 Sep. 7 at 9:40 PM
$VKTX All these recent cardiovascular outcome trial failures (CVOTs) make maintenance GLP therapies more valuable. Treating inflammatory cascades is clearly only part of the treatment algorithm to improve MACE. VK2735 will almost certainly be the third company behind LLY/NVO to have maintenance options in both SQ/PO forms…
0 · Reply
Auto_MA_T_Ka
Auto_MA_T_Ka Sep. 7 at 9:36 PM
Viking Therapeutics $VKTX consolidates in-between its converging weekly moving average support and resistance bands. Resistance: 111/118w SMAs @ $37.57-$38.50 VKTX @ $34.87 Support: 219/348w SMAs & 361-week EMA @ $21.13-$30.24
0 · Reply
bavariaron
bavariaron Sep. 7 at 9:08 PM
$VKTX ** I predict a 25% chance… ** I predict a 25% chance data drops this week. The PR will occur on a Tuesday or Thursday. Chances increase by 25% every week. 😂🤣😎 VKTX Long-Term
0 · Reply
DarkOrb
DarkOrb Sep. 7 at 8:46 PM
$VKTX Wow - great share! "That's what we have. At the same time, I tell my team, we don't have a monopoly of good ideas. So, let's be humble and see who who else has something that's either better than what we have ourselves to fill the gap or earlier than us can be launched. So, so, so we're also looking into partnerships, acquisitions and trying to basically see where else we could um um um complement.All the good things we have on our own." Right at the end around the 34 minute mark.
0 · Reply
Stockman824
Stockman824 Sep. 7 at 8:38 PM
$VKTX all I know is BL better step the F up this month and hit these shorts with everything he has and get some of the big guys backing him up with $$$$$$$
0 · Reply
biolover
biolover Sep. 7 at 7:48 PM
$VKTX New observations from $NVO CEO repeated mentioning of GIP - novo realized what is missing - and first time he talks about partnering with others and not just M&A ? He acknowledges need for “ earlier launched assets than us “. Will get interesting next few weeks. $ABBV and others watching all that. https://finance.yahoo.com/video/weight-loss-just-beginning-glp-100000472.html?contentType=VIDEO
3 · Reply
ENGser
ENGser Sep. 7 at 6:56 PM
$VKTX 40% Chance that news will drop tomorrow 🎉
2 · Reply
DG20
DG20 Sep. 7 at 6:44 PM
$VKTX I believe you sold at $73 (maybe even for a small profit) but the $45 is a straight up lie. On Feb 26th 2024 it closed at $38 and then gapped up on the 27th. It never hit $45 in the interim. The next time it crossed $45 was Dec 2024 and has been mired in the $20’s/30’s since. Best of luck to you but stop lying 🤥
2 · Reply
snowgoose2000
snowgoose2000 Sep. 7 at 5:55 PM
$VKTX stockplay100 and the rest of the longs are a little stupid in my book . Y’all keep saying you can’t wait till the shorts get crushed. Let me educate y’all We all cover our short if short term indicators suggest the stock has potential to break out. ( it’s called trading) I was long when it broke out of $45 a couple years ago and broke through $90, full disclosure sold way to early at $73 So for those of you who think shorts get crushed, only chance is a huge gap open from news. Most of the time we know news is coming as the stock starts trending much higher. So yes we do it both ways (but rarely long)
0 · Reply
vu_jade
vu_jade Sep. 7 at 5:45 PM
$VKTX One Tuesday it will be too late! #SKOL
0 · Reply
Latest News on VKTX
Viking Therapeutics Slides: Corporate presentation

Aug 5, 2026, 9:00 AM EDT - 4 weeks ago

Viking Therapeutics Slides: Corporate presentation


Viking Therapeutics files automatic mixed securities shelf

2026-07-30T10:15:48.000Z - 5 weeks ago

Viking Therapeutics files automatic mixed securities shelf


Viking Therapeutics Earnings Call Transcript: Q2 2026

Jul 29, 2026, 4:30 PM EDT - 5 weeks ago

Viking Therapeutics Earnings Call Transcript: Q2 2026


Viking Therapeutics Earnings release: Q2 2026

Jul 29, 2026, 4:30 PM EDT - 5 weeks ago

Viking Therapeutics Earnings release: Q2 2026


Viking Therapeutics Quarterly report: Q2 2026

Jul 29, 2026, 4:30 PM EDT - 5 weeks ago

Viking Therapeutics Quarterly report: Q2 2026


Viking Therapeutics Slides: Corporate presentation

Jul 14, 2026, 8:00 AM EDT - 7 weeks ago

Viking Therapeutics Slides: Corporate presentation


Viking Therapeutics begins Phase 1 SAD clinical trial of VK3019

2026-06-24T11:10:10.000Z - 2 months ago

Viking Therapeutics begins Phase 1 SAD clinical trial of VK3019


Viking Therapeutics management to meet with B. Riley

2026-06-15T16:23:17.000Z - 2 months ago

Viking Therapeutics management to meet with B. Riley


Viking Therapeutics Slides: Corporate presentation

Jun 7, 2026, 7:00 AM EDT - 3 months ago

Viking Therapeutics Slides: Corporate presentation


Viking Therapeutics initiated with a Buy at Lake Street

2026-05-28T13:23:51.000Z - 3 months ago

Viking Therapeutics initiated with a Buy at Lake Street


Viking Therapeutics assumed with a Buy at Truist

2026-05-27T15:22:10.000Z - 3 months ago

Viking Therapeutics assumed with a Buy at Truist


Viking Therapeutics Earnings Call Transcript: Q1 2026

Apr 29, 2026, 4:30 PM EDT - 4 months ago

Viking Therapeutics Earnings Call Transcript: Q1 2026


Viking Therapeutics Earnings release: Q1 2026

Apr 29, 2026, 4:30 PM EDT - 4 months ago

Viking Therapeutics Earnings release: Q1 2026


Viking Therapeutics Quarterly report: Q1 2026

Apr 29, 2026, 4:30 PM EDT - 4 months ago

Viking Therapeutics Quarterly report: Q1 2026


Viking Therapeutics Proxy statement: Proxy filing

Apr 1, 2026, 8:00 AM EDT - 5 months ago

Viking Therapeutics Proxy statement: Proxy filing


Viking Therapeutics Proxy statement: Proxy filing

Apr 1, 2026, 8:00 AM EDT - 5 months ago

Viking Therapeutics Proxy statement: Proxy filing


Viking Therapeutics Slides: Corporate presentation

Mar 13, 2026, 7:00 AM EDT - 5 months ago

Viking Therapeutics Slides: Corporate presentation


Viking Therapeutics Earnings Call Transcript: Q4 2025

Feb 11, 2026, 4:30 PM EST - 6 months ago

Viking Therapeutics Earnings Call Transcript: Q4 2025


Viking Therapeutics Annual report: Q4 2025

Feb 11, 2026, 4:30 PM EST - 6 months ago

Viking Therapeutics Annual report: Q4 2025


Viking Therapeutics Earnings release: Q4 2025

Feb 11, 2026, 4:30 PM EST - 6 months ago

Viking Therapeutics Earnings release: Q4 2025


Viking Therapeutics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 7 months ago

Viking Therapeutics Slides: Corporate presentation


Viking Therapeutics Slides: Corporate presentation

Dec 9, 2025, 7:00 AM EST - 9 months ago

Viking Therapeutics Slides: Corporate presentation


Viking Therapeutics Slides: Corporate Presentation

Nov 19, 2025, 7:00 AM EST - 9 months ago

Viking Therapeutics Slides: Corporate Presentation


Viking Therapeutics Earnings Call Transcript: Q3 2025

Oct 22, 2025, 4:30 PM EDT - 10 months ago

Viking Therapeutics Earnings Call Transcript: Q3 2025


Viking Therapeutics Quarterly report: Q3 2025

Oct 22, 2025, 4:30 PM EDT - 10 months ago

Viking Therapeutics Quarterly report: Q3 2025


Viking Therapeutics Earnings release: Q3 2025

Oct 22, 2025, 4:30 PM EDT - 10 months ago

Viking Therapeutics Earnings release: Q3 2025


Viking Therapeutics Slides: Corporate Presentation

Oct 1, 2025, 7:00 AM EDT - 11 months ago

Viking Therapeutics Slides: Corporate Presentation


Viking Therapeutics: What's Happening With VKTX Stock?

Aug 20, 2025, 9:50 AM EDT - 1 year ago

Viking Therapeutics: What's Happening With VKTX Stock?


Viking Therapeutics Transcript: Study Result

Aug 19, 2025, 8:00 AM EDT - 1 year ago

Viking Therapeutics Transcript: Study Result


Viking Therapeutics Press release: Study Result

Aug 19, 2025, 8:00 AM EDT - 1 year ago

Viking Therapeutics Press release: Study Result


Viking Therapeutics Earnings Call Transcript: Q2 2025

Jul 23, 2025, 4:30 PM EDT - 1 year ago

Viking Therapeutics Earnings Call Transcript: Q2 2025


Viking Therapeutics Quarterly report: Q2 2025

Jul 23, 2025, 4:30 PM EDT - 1 year ago

Viking Therapeutics Quarterly report: Q2 2025


Viking Therapeutics Earnings release: Q2 2025

Jul 23, 2025, 4:30 PM EDT - 1 year ago

Viking Therapeutics Earnings release: Q2 2025


Viking Therapeutics Slides: Corporate Presentation

Jul 3, 2025, 7:00 AM EDT - 1 year ago

Viking Therapeutics Slides: Corporate Presentation


Viking Therapeutics Slides: Corporate Presentation

Jun 14, 2025, 7:00 AM EDT - 1 year ago

Viking Therapeutics Slides: Corporate Presentation


Viking Therapeutics Slides: Company Presentation

May 2, 2025, 7:00 AM EDT - 1 year ago

Viking Therapeutics Slides: Company Presentation


Viking Therapeutics Earnings Call Transcript: Q1 2025

Apr 23, 2025, 4:30 PM EDT - 1 year ago

Viking Therapeutics Earnings Call Transcript: Q1 2025


Viking Therapeutics Quarterly report: Q1 2025

Apr 23, 2025, 4:30 PM EDT - 1 year ago

Viking Therapeutics Quarterly report: Q1 2025


Viking Therapeutics Earnings release: Q1 2025

Apr 23, 2025, 4:30 PM EDT - 1 year ago

Viking Therapeutics Earnings release: Q1 2025


Viking Therapeutics Proxy statement: Proxy Filing

Apr 23, 2025, 8:00 AM EDT - 1 year ago

Viking Therapeutics Proxy statement: Proxy Filing


Viking Therapeutics Proxy statement: Proxy Filing

Apr 23, 2025, 8:00 AM EDT - 1 year ago

Viking Therapeutics Proxy statement: Proxy Filing


Viking Therapeutics Proxy statement: Proxy Filing

Apr 8, 2025, 8:00 AM EDT - 1 year ago

Viking Therapeutics Proxy statement: Proxy Filing


Viking Therapeutics Proxy statement: Proxy Filing

Apr 8, 2025, 8:00 AM EDT - 1 year ago

Viking Therapeutics Proxy statement: Proxy Filing


DG20
DG20 Sep. 7 at 9:40 PM
$VKTX All these recent cardiovascular outcome trial failures (CVOTs) make maintenance GLP therapies more valuable. Treating inflammatory cascades is clearly only part of the treatment algorithm to improve MACE. VK2735 will almost certainly be the third company behind LLY/NVO to have maintenance options in both SQ/PO forms…
0 · Reply
Auto_MA_T_Ka
Auto_MA_T_Ka Sep. 7 at 9:36 PM
Viking Therapeutics $VKTX consolidates in-between its converging weekly moving average support and resistance bands. Resistance: 111/118w SMAs @ $37.57-$38.50 VKTX @ $34.87 Support: 219/348w SMAs & 361-week EMA @ $21.13-$30.24
0 · Reply
bavariaron
bavariaron Sep. 7 at 9:08 PM
$VKTX ** I predict a 25% chance… ** I predict a 25% chance data drops this week. The PR will occur on a Tuesday or Thursday. Chances increase by 25% every week. 😂🤣😎 VKTX Long-Term
0 · Reply
DarkOrb
DarkOrb Sep. 7 at 8:46 PM
$VKTX Wow - great share! "That's what we have. At the same time, I tell my team, we don't have a monopoly of good ideas. So, let's be humble and see who who else has something that's either better than what we have ourselves to fill the gap or earlier than us can be launched. So, so, so we're also looking into partnerships, acquisitions and trying to basically see where else we could um um um complement.All the good things we have on our own." Right at the end around the 34 minute mark.
0 · Reply
Stockman824
Stockman824 Sep. 7 at 8:38 PM
$VKTX all I know is BL better step the F up this month and hit these shorts with everything he has and get some of the big guys backing him up with $$$$$$$
0 · Reply
biolover
biolover Sep. 7 at 7:48 PM
$VKTX New observations from $NVO CEO repeated mentioning of GIP - novo realized what is missing - and first time he talks about partnering with others and not just M&A ? He acknowledges need for “ earlier launched assets than us “. Will get interesting next few weeks. $ABBV and others watching all that. https://finance.yahoo.com/video/weight-loss-just-beginning-glp-100000472.html?contentType=VIDEO
3 · Reply
ENGser
ENGser Sep. 7 at 6:56 PM
$VKTX 40% Chance that news will drop tomorrow 🎉
2 · Reply
DG20
DG20 Sep. 7 at 6:44 PM
$VKTX I believe you sold at $73 (maybe even for a small profit) but the $45 is a straight up lie. On Feb 26th 2024 it closed at $38 and then gapped up on the 27th. It never hit $45 in the interim. The next time it crossed $45 was Dec 2024 and has been mired in the $20’s/30’s since. Best of luck to you but stop lying 🤥
2 · Reply
snowgoose2000
snowgoose2000 Sep. 7 at 5:55 PM
$VKTX stockplay100 and the rest of the longs are a little stupid in my book . Y’all keep saying you can’t wait till the shorts get crushed. Let me educate y’all We all cover our short if short term indicators suggest the stock has potential to break out. ( it’s called trading) I was long when it broke out of $45 a couple years ago and broke through $90, full disclosure sold way to early at $73 So for those of you who think shorts get crushed, only chance is a huge gap open from news. Most of the time we know news is coming as the stock starts trending much higher. So yes we do it both ways (but rarely long)
0 · Reply
vu_jade
vu_jade Sep. 7 at 5:45 PM
$VKTX One Tuesday it will be too late! #SKOL
0 · Reply
biolover
biolover Sep. 7 at 4:59 PM
$VKTX In anticipation of Sep data I attached below DC rate from any cause ( top doses ) from $LLY TZP ( dc 18%) vs $NVO semaglutide (22% ) NEJM trial …. From retatrutide phase 2 NEJM trial ( DC 25 %) and Triumph phase 3 (same 25%) Eloralentide ( DC 17-25 %) Viking trial is shorter though. But most DC from AEs occurs during escalation phase. Reta may be different as top dose can stress humans with excessive anorexia and sometimes vomit. Will see how much VK2735 top dose impacts compliance.
0 · Reply
DG20
DG20 Sep. 7 at 3:45 PM
$VKTX This is what @biolover wrote on X. He does his best work there under the title @Bioinvestor24. https://x.com/bioinvestor24/status/2096662849385054615?s=46&t=m2EBEfPjxzf1wD0mD7MUyg
1 · Reply
Flying_Trader2
Flying_Trader2 Sep. 7 at 2:56 PM
$VKTX had a bad dream that BL didn’t drop data before Fridays FS chat then used that venue to talk about how vomit rates or some other metrics didn’t matter in the maintenance trail because it had different objectives or some sort of nonsense to try and manage expectations before dropping a bomb Friday AHs. I sure hope he drops data if not Tuesday then Wed or Thurs and proves it was just a bad dream.
2 · Reply
whiskyqueen
whiskyqueen Sep. 7 at 2:53 PM
$VKTX @biolover Any thoughts on this Novo licensed asset?
2 · Reply
VentureBack
VentureBack Sep. 7 at 2:27 PM
$VKTX You can’t set this up any better weekend, market closed Monday, upcoming fireside chats, data drop…. Pent up buying demand 🚀🚀🚀🚀🚀🚀🚀🚀🚀
0 · Reply
hopedieslast
hopedieslast Sep. 7 at 1:11 PM
$VKTX you failed to recognize that that is Euro’s. Distinction without a difference basically. price is approx.the same in $’s.
1 · Reply
GuruRanger
GuruRanger Sep. 7 at 7:51 AM
$VKTX pretty sure under the definition of narcissist it gives Cubie as an example. They blocked me so I guess I won't have to see them anymore. Enjoy your Labor Day Holiday everyone.
0 · Reply
AlgoFolks
AlgoFolks Sep. 7 at 6:41 AM
$VKTX no big deal due to low volume but intresting
3 · Reply
VentureBack
VentureBack Sep. 7 at 1:37 AM
$VKTX Never seen so many people on this board 🤣🤣🤣
0 · Reply
saifnila2
saifnila2 Sep. 6 at 9:50 PM
$VKTX only thing that counts is how much weight loss and side effects. Whether there is a plateau or not. And whether there is continued weight loss in the maintenance phase or weight gain or flat. That is the bottom line my dear friends.
3 · Reply
VentureBack
VentureBack Sep. 6 at 8:27 PM
$VKTX By locking down massive API supply commitments and contract manufacturing agreements (CMOs/CDMOs) with CordenPharma and three other suppliers, Viking removes execution risk. If a Big Pharma suitor wants to acquire or partner with Viking, they are no longer just buying a molecule; they are buying a turnkey, market-ready asset. This forces suitors to offer a higher premium. Insurance policy simple as that
0 · Reply
Lillyfee
Lillyfee Sep. 6 at 8:20 PM
$VKTX What do we expect? Are they really going alone?
2 · Reply